February 14, 2025

Additional Ophthalmic Complications Associated with GLP-1 Use Identified in Case Series

AAO provides guidance in response.

Conexiant

February 14, 2025

Researchers Evaluate AI-based Smart Glasses and Apps in Patients With Vision Impairment

The tools significantly improved participants' ability to complete text-based tasks.

Conexiant

February 14, 2025

Signs of Immunological Memory in Cases of Occlusive Retinal Vasculitis Following Rechallenge with Faricimab

Real-world case series suggests caution with even mild IOI.

Conexiant

February 14, 2025

Researchers Find Minimal Risk of Adverse Events in Mobile Eye Screening Programs

The most common mild, self-resolving symptoms included eye pain and nervousness about procedures.

Conexiant

February 13, 2025

Study Offers Global Feedback on Improvements to DME Care

48.4% of patients cited transportation difficulties as a barrier to attending appointments, while 45% of patients reported that their other chronic diseases made it difficult to maintain eye care visits.

Conexiant

January 22, 2025

Medicare Advantage and Traditional Medicare Enrollees’ Use of Benefits

Socioeconomically disadvantaged patients tend to use less care relative to their medical needs—regardless of their coverage—than others.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

July 03, 2024

Semaglutide Linked to Vision-Threatening Eye Disorder

New study finds that 8.9% of type 2 diabetes patients taking semaglutide experienced NAION, compared to 1.8% of those on non-GLP-1 diabetes drugs.

Reuters